Vectibix (Panitumumab) 100mg

VECTIBIX (Panitumumab 100mg) is a monoclonal antibody used for metastatic colorectal cancer treatment. This EGFR inhibitor helps slow tumor growth when refrigerated at 2-8°C. Suitable for patients requiring targeted therapy options. Short-term storage guidance applies.

Strength

100mg

Pack Size

Storage

2-8ºC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Panitumumab 100mg is primarily used to treat metastatic colorectal cancer in patients whose tumors express EGFR. It may be prescribed after other treatments fail or as part of combination therapy. This medication targets cancer cells to slow disease progression. Patients often ask what is Panitumumab used for when exploring advanced cancer treatment options.

Side Effects

Common effects may include skin reactions like rash or dryness, fatigue, or gastrointestinal discomfort. Some patients report changes in nail or hair appearance during treatment. These effects vary by individual and should be discussed with a healthcare provider.

Precautions & Warnings

Keep Panitumumab 100mg refrigerated between 2-8°C and protect from light. Do not freeze or shake the vial. Handle with care to avoid contamination. Always check expiration dates before use. Consult a healthcare professional for proper storage and disposal methods.

Avoid Interactions

Panitumumab may interact with other medications affecting skin or immune response. Avoid live vaccines during treatment due to potential reduced effectiveness. Inform your doctor about all prescriptions, over-the-counter drugs, or supplements you’re taking. Some interactions may require dose adjustments or monitoring.

References

Frequently Asked Questions

Panitumumab 100mg is used to treat metastatic colorectal cancer in patients with EGFR-expressing tumors.

Store Panitumumab 100mg refrigerated between 2-8°C and protect from light.

Panitumumab may be used alone or combined with other therapies, but this depends on individual treatment plans.

Common side effects may include skin reactions, fatigue, or gastrointestinal discomfort.

Panitumumab is a targeted therapy, not a traditional chemotherapy agent.

Published by GNH India Pharmaceuticals Limited

Last updated: 17 Jun 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.